MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Todays Market
- Indian Stock Market Updates June 20, 2019
PIRAMAL ENTERPRISES Surges by 5%; BSE HEALTHCARE Index Up 1.6%
Thu, 20 Jun 12:58 PM
PIRAMAL ENTERPRISES share price has zoomed 5% and is presently trading at Rs 1,837.
Meanwhile, the BSE HEALTHCARE Index is at 12,723 (up 1.6%).
Among the top Gainers in the BSE HEALTHCARE Index today are PIRAMAL ENTERPRISES (up 5.3%) and BLISS GVS PHARMA (up 7.2%).
PFIZER (down 0.2%) and ASTRAZENECA PHARMA (down 0.3%) are among the top losers today.
Over the last one year, PIRAMAL ENTERPRISES has moved down from Rs 2,542 to Rs 1,837, registering a loss of Rs 705 (down 27.8%).
On the other hand, the BSE HEALTHCARE has moved down from 14,228 to 12,723, loss of 1,505 points (down 10.7%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were MERCK (up 60.7%), DIVIS LABORATORIES (up 44.8%) and IPCA LABS (up 35.0%).
What About the Benchmark Indices?
The BSE Sensex is at 39,361 (up 0.6%).
The top gainers among the BSE Sensex stocks today are YES BANK (up 5.2%), SUN PHARMA (up 3.6%) and INDUSIND BANK (up 2.8%). Other gainers include VEDANTA LTD (up 1.8%) and BAJAJ AUTO (up 1.6%). The most traded stocks in the BSE Sensex are YES BANK and TATA MOTORS.
In the meantime, NSE Nifty is at 11,761 (up 0.5%). INDIABULLS HOU. FIN. (up 5.7%) and YES BANK (up 5.2%) are among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved up from 35,287 to 39,361, registering a gain of 4,074 points (up 11.5%).
PIRAMAL ENTERPRISES Financial Update...
PIRAMAL ENTERPRISES net profit down at Rs 3 billion for the quarter ended March 2019, compared to a loss of Rs 5 billion a year ago. Net Sales rose 5.5% to Rs 36.8 billion during the period as against Rs 34.9 billion in January-March 2018.
For the year ended March 2018, PIRAMAL ENTERPRISES reported 343.2% increase in net profit to Rs 48.4 billion compared to net profit of Rs 10.9 billion during FY17.
Revenue of the company grew 24.5% to Rs 106 billion during FY18.
The current Price to earnings ratio of PIRAMAL ENTERPRISES, based on rolling 12 month earnings, stands at 27.0x.
Indian Share Market Update: Top Gainers and Losers
|
| |
Stock Market Updates
Indian Indices Witness Sharp Selling, India's Crude Oil Imports, and Top Cues in Focus Today (Today's Market)
Aug 23, 2019 Pre-OpenIndia share markets witnessed sharp selling pressure yesterday and ended their day deep in the red.At the closing bell yesterday, the BSE Sensex stood lower by 587 points (down 1.6%).
View More Indian Share Market NewsMost Popular
This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)
Aug 12, 2019My experience at the recent AGM of this smallcap company which has financials of any FMCG major.
Interest Rates Are Low. Buy Solid Dividend Stocks Instead(The 5 Minute Wrapup)
Aug 13, 2019The dividends paid by these stocks are helpful when interest rates are falling.
Smallcaps that Will Outperform in the Market Rebound(Profit Hunter)
Aug 12, 2019Only These Smallcaps Will Give Historic Returns in the Future.
My Top 3 Dividend Stocks to Buy Now(Profit Hunter)
Aug 19, 2019As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.
Chandrayaan 2 Heads to the Moon and It's Good News for These Stocks(The 5 Minute Wrapup)
Aug 14, 2019Why investors should take note of India's advantage as a low cost satellite launcher...
More|
| |
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster requests your view! Post a comment on "PIRAMAL ENTERPRISES Surges by 5%; BSE HEALTHCARE Index Up 1.6%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!